FDA said in a recall announcement on August 9 that it was recalling Levothyroxine and Liothyronine 15 mg, 30 mg, 60 mg, 90 mg, and 120 mg thyroid tablets “as a precaution.”
Westminster Pharmaceuticals, the company that manufactures the drugs, said in a recorded statement, “If your medication is dosed in micrograms (mcg), your medication is not included in this recall.”
FDA said the affected Levothyroxine and Liothyronine were manufactured using active pharmaceutical ingredients that were sourced prior to its import alert. Due to the fact that both drugs are used to treat serious medical conditions, FDA recommended that patients taking them should continue doing so until they contact their physician and have found a replacement drug.
“Westminster Pharmaceuticals aims to ensure that integrity is embedded in our reputation through the products we develop and market,” said Gajan Mahendiran, CEO of Westminster Pharmaceuticals. ”We will never compromise when it comes to providing our patients with the caliber of medication they deserve. While we stand behind the quality of our product, we are taking the utmost precaution by recalling our Thyroid, USP Tablets only to the wholesale level due to a recent inspection by the FDA at one of our active ingredient manufacturers.”
Click on the following link to view a complete list of medications affected by the recall.